investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Illuminating the Druggable Genome

Tudor Oprea

7 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Larry A Sklar

University of New Mexico

Albuquerque, United States

Stephen C Schurer

University of Miami

Coral Gables, United States

Soren Brunak

Novo Nordisk (Denmark)

Copenhagen, Denmark

Tudor Oprea

University of New Mexico

Albuquerque, United States

Related projects

Jon Clardy

Novel Therapeutic Agents from the Bacterial Symbionts of Brazilian Invertebrates

All cancers but non-melanoma skin cancer

Paul B. Jacobsen

Behavioral Oncology Education & Career Development

All cancers but non-melanoma skin cancer

Collin Melton

Identification, Characterization, and Prediction of Cancer Driver Mutations in Regulatory Regions

All cancers but non-melanoma skin cancer

Peter R Parham

Interactions Between HLA Class I and Cytolytic Lymphocytes

All cancers but non-melanoma skin cancer

Brendan D. Manning

Decoding and targeting the PI3K-mTOR signaling network in cancer

All cancers but non-melanoma skin cancer

George Q Daley

LIN28/let-7 MECHANISMS IN REPROGRAMMING AND METABOLISM

All cancers but non-melanoma skin cancer

Petra Hajkova

Reprogramming and Chromatin

All cancers but non-melanoma skin cancer

Douglas R Green

RIPK-dependent necrosis in development and cancer

All cancers but non-melanoma skin cancer

Pathology

Giovanna Tosato

Study of the Roles of SDF1 and CXCR4 in Hematopoiesis

All cancers but non-melanoma skin cancer

Hematology and hematologic malignancies